Citation Impact
Citing Papers
Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases
2016 Standout
Anti-cancer natural products isolated from chinese medicinal herbs
2011 Standout
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Psoriasis
2014
The economics of treatment in early rheumatoid arthritis
2009
A Multicenter, Open Label, Double Tympanocentesis Study of High Dose Cefdinir in Children With Acute Otitis Media at High Risk of Persistent or Recurrent Infection
2006
Rheumatoid arthritis
2018 Standout
Curcumin, the Golden Spice From Indian Saffron, Is a Chemosensitizer and Radiosensitizer for Tumors and Chemoprotector and Radioprotector for Normal Organs
2010 Standout
Differences in annual medication costs and rates of dosage increase between tumor necrosis factor-antagonist therapies for rheumatoid arthritis in a managed care population
2009
Synovial Tissue Inflammation Mediated by Autoimmune T Cells
2019 StandoutNobel
TNF inhibitor therapy for rheumatoid arthritis
2012
Nanotechnology as a therapeutic tool to combat microbial resistance
2013 Standout
Comparison of Staphylococcus aureus From Skin and Soft-Tissue Infections in US Emergency Department Patients, 2004 and 2008
2011
The Diagnosis and Management of Acute Otitis Media
2013 Standout
Secukinumab efficacy in anti-TNF-naive and anti-TNF-experienced subjects with active ankylosing spondylitis: results from the MEASURE 2 Study
2016
The effect of biological agents on work participation in rheumatoid arthritis patients: a systematic review
2011
Oral β-lactams applied to uncomplicated infections of skin and skin structures
2007
Discovery of curcumin, a component of golden spice, and its miraculous biological activities
2011 Standout
Incorporating the Treat-to-Target Concept in Rheumatoid Arthritis
2012
The Role of β-Hemolytic Streptococci in Causing Diffuse, Nonculturable Cellulitis
2010
Role of Folate Antagonists in the Treatment of Methicillin-Resistant Staphylococcus aureus Infection
2008
Impact of intensive treatment and remission on health-related quality of life in early and established rheumatoid arthritis
2016
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Registers of the Swedish total population and their use in medical research
2016 Standout
Newer Biological Agents in Rheumatoid Arthritis
2010
The economic burden of gout: A systematic review
2015
Rheumatoid arthritis
2010 Standout
β-Lactams and β-Lactamase Inhibitors: An Overview
2016 Standout
Identification of cytomegalovirus (CMV)pp65 antigen-specific human monoclonal antibodies using single B cell-based antibody gene cloning from melanoma patients
2010
Hidradenitis suppurativa
2020 Standout
10 Years of GWAS Discovery: Biology, Function, and Translation
2017 Standout
The immunopathology of sepsis and potential therapeutic targets
2017 Standout
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Biological vs Conventional Combination Treatment and Work Loss in Early Rheumatoid Arthritis
2013
A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial
2019
The global burden of IBD: from 2015 to 2025
2015 Standout
The value of early intervention in RA—a window of opportunity
2011
The biosimilar road in inflammatory bowel disease: The right way?
2014
Nrf2 activation improves experimental rheumatoid arthritis
2023 StandoutNobel
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
A Randomized, Pilot Study to Assess the Efficacy and Safety of Curcumin in Patients with Active Rheumatoid Arthritis
2012 Standout
Management of Skin and Soft-Tissue Infection
2008
Contemporary Prevalence of Gout and Hyperuricemia in the United States and Decadal Trends: The National Health and Nutrition Examination Survey, 2007–2016
2019 Standout
Clinically Important Changes in Short Form 36 Health Survey Scales for Use in Rheumatoid Arthritis Clinical Trials: The Impact of Low Responsiveness
2014
Psoriasis Pathogenesis and Treatment
2019 Standout
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Bacterial Antibiotic Resistance: The Most Critical Pathogens
2021 Standout
Recommendations for the management of comorbidity in hidradenitis suppurativa
2017
Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review
2018 Standout
Gout
2021 Standout
Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis
2016
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
Increased cardiovascular mortality associated with gout: a systematic review and meta-analysis
2013
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
2020 Standout
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Generic quality-of-life assessment in rheumatoid arthritis.
2007
Works of Mary Cifaldi being referenced
A comparison of 5 days of therapy with cefdinir or azithromycin in children with acute otitis media: A multicenter, prospective, single-blind study
2005
Cost of care for patients with rheumatoid arthritis receiving TNF-antagonist therapy using claims data
2007
Improvement in work place and household productivity for patients with early rheumatoid arthritis treated with adalimumab plus methotrexate: Work outcomes and their correlations with clinical and radiographic measures from a randomized controlled trial companion study
2010
Health-related Quality of Life Outcomes of Adalimumab for Patients with Early Rheumatoid Arthritis: Results from a Randomized Multicenter Study
2011
Cost Per Responder Associated with Biologic Therapies for Crohn’s Disease, Psoriasis, and Rheumatoid Arthritis
2012
Clinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agents
2012
Annual Incremental Health Benefit Costs and Absenteeism Among Employees With and Without Rheumatoid Arthritis
2013
Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: A population‐based study
2011
Cost-Effectiveness of Sequential Therapy with Tumor Necrosis Factor Antagonists in Early Rheumatoid Arthritis
2008
Workplace impacts of anti-TNF therapies in rheumatoid arthritis: review of the literature
2009
Matching-adjusted indirect comparison of adalimumab vs etanercept and infliximab for the treatment of psoriatic arthritis
2013
Adalimumab plus methotrexate improved SF-36 scores and reduced the effect of rheumatoid arthritis (RA) on work activity for patients with early RA.
2008
Prevalence of Axial Spondyloarthritis in United States Rheumatology Practices: Assessment of SpondyloArthritis International Society Criteria Versus Rheumatology Expert Clinical Diagnosis
2013
Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults
2006
Societal cost of rheumatoid arthritis patients in the US
2009
Retrospective claims data analysis of dosage adjustment patterns of TNF antagonists among patients with rheumatoid arthritis
2008
Improvement and longterm maintenance of quality of life during treatment with adalimumab in severe rheumatoid arthritis.
2007